[Palliative Care Leader Amy Abernethy appointed] Duke University names five new Trustees

[Palliative Care Leader Amy Abernethy appointed] Duke University names five new Trustees
Press Release; 7/2/24
Five new members joined the Duke University Board of Trustees on July 1, university officials announced Tuesday. The new trustees are Amy Abernethy, Melissa Bernstein, Michael Stone, Andrew Greene, and Rickard Stureborg... Abernethy M.D.’94, HS’94-’01 is co-founder of Highlander Health, an organization focused on advancing evidence generation for the new era of medical innovation. An internationally known oncologist, health data expert, and digital health leader, Abernethy is a champion for accelerating the pace at which safe and effective treatments reach patients. She is the former principal deputy commissioner of the U.S. Food and Drug Administration, where she led initiatives in advancing clinical evidence generation and personalized health care and served as the agency's acting chief information officer. More recently, Abernethy served as chief medical officer and president of product development at Verily, Alphabet’s precision health business. Earlier she was Flatiron Health’s first chief medical officer and chief scientific officer. She was also previously professor of medicine at the Duke University School of Medicine and director of the Center for Learning Health Care in the Duke Clinical Research Institute and the Duke Cancer Care Research Program in the Duke Cancer Institute. A hematologist/oncologist, palliative medicine physician, and recipient of the 2021 Distinguished Alumna Award from Duke University School of Medicine, Abernethy has authored more than 500 publications.
Publisher's Note: Congratulations Amy!